Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009597HBVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS10011300HBVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS10041989HBVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS30051950HIVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS20000113HPVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS20001686HPVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS44048722HTLV-1ENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TCGA Plot Options
Drug Information
GeneCALCRL
DrugBank IDDB04869
Drug NameOlcegepant
Target IDBE0009009
UniProt IDQ16602
Regulation Typeantagonist
PubMed IDs28165287; 34015169
CitationsWalker CS, Raddant AC, Woolley MJ, Russo AF, Hay DL: CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured. Cephalalgia. 2017 Jan 1:333102417691762. doi: 10.1177/0333102417691762.@@Liu J, Liu L, Zhao M, Ding N, Ge N, Daugherty SL, Beckel JM, Wang S, Zhang X: Activation of TRPM8 channel inhibits contraction of the isolated human ureter. Neurourol Urodyn. 2021 Aug;40(6):1450-1459. doi: 10.1002/nau.24689. Epub 2021 May 20.
GroupsInvestigational
Direct ClassificationDipeptides
SMILESNCCCC[C@H](NC(=O)[C@@H](CC1=CC(Br)=C(O)C(Br)=C1)NC(=O)N1CCC(CC1)N1CC2=C(NC1=O)C=CC=C2)C(=O)N1CCN(CC1)C1=CC=NC=C1
Pathways
PharmGKB
ChEMBLCHEMBL207197